SEC Form 4 · accession 0001179110-15-014632
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Washington
Officer — EVP, CFO
Period of report
Nov 5, 2015
Accepted (ET)
Nov 9, 2015 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2015 | M | 6,000 | $0.00 | A | 33,724 | D | |
| Common Stock | Nov 5, 2015 | F | 3,108 | $107.83 | D | 30,616 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Nov 5, 2015 | M | 6,000 | D | — | — | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
- F2The restricted stock units have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 20% every year thereafter until fully vested.